Cartesian Therapeutics, Inc removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.57 USD | -3.50% | -7.04% | +18.80% |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
May. 22 | Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.80% | 437M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Cartesian Therapeutics, Inc.(NasdaqGM: RNAC) dropped from NASDAQ Biotechnology Index